These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2007776)

  • 21. Clinical and biochemical characteristics and genotype-phenotype correlation in Finnish variegate porphyria patients.
    von und zu Fraunberg M; Timonen K; Mustajoki P; Kauppinen R
    Eur J Hum Genet; 2002 Oct; 10(10):649-57. PubMed ID: 12357337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma fluorescence scanning and fecal porphyrin analysis for the diagnosis of variegate porphyria: precise determination of sensitivity and specificity with detection of protoporphyrinogen oxidase mutations as a reference standard.
    Hift RJ; Davidson BP; van der Hooft C; Meissner DM; Meissner PN
    Clin Chem; 2004 May; 50(5):915-23. PubMed ID: 14976149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Porphyria cutanea tarda (PCT): an unusual manifestation of obstructive liver disease due to cholelithiasis.
    Lim KB; Tan T; Ali BA; Seah MM
    Singapore Med J; 1985; 26(4-5):391-4. PubMed ID: 4071096
    [No Abstract]   [Full Text] [Related]  

  • 24. Propofol as an i.v. anaesthetic induction agent in variegate porphyria.
    Meissner PN; Harrison GG; Hift RJ
    Br J Anaesth; 1991 Jan; 66(1):60-5. PubMed ID: 1997060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gallstones in children.
    Todd DJ
    Am J Dis Child; 1991 Sep; 145(9):971-2. PubMed ID: 1877575
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of canthaxanthin on the photocutaneous manifestations of porphyria.
    Eales L
    S Afr Med J; 1978 Dec; 54(25):1050-2. PubMed ID: 371027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterisation of a deletion (537delAT) in the protoporphyrinogen oxidase gene in a South African variegate porphyria family.
    Corrigall AV; Hift RJ; Hancock V; Meissner D; Davids L; Kirsch RE; Meissner PN
    Hum Mutat; 1998; 12(6):403-7. PubMed ID: 9829909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elective cholecystectomy performed on patient with variegate porphyria-Propofol-based total intravenous anesthesia with target-controlled infusion.
    Kuźmiński A; Aporowicz M; Brol M; Żołnowska A; Masternak M
    J Clin Anesth; 2016 Dec; 35():114-117. PubMed ID: 27871506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variegate porphyria. Twelve years' experience in Finland.
    Mustajoki P
    Q J Med; 1980; 49(194):191-203. PubMed ID: 7433635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variegate porphyria: identification of a nonsense mutation in the protoporphyrinogen oxidase gene.
    Frank J; Jugert FK; Kalka K; Goerz G; Merk HF; Christiano AM
    J Invest Dermatol; 1998 Apr; 110(4):449-51. PubMed ID: 9540990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the protoporphyrinogen oxidase gene in patients with variegate porphyria.
    Deybach JC; Puy H; Robréau AM; Lamoril J; Da Silva V; Grandchamp B; Nordmann Y
    Hum Mol Genet; 1996 Mar; 5(3):407-10. PubMed ID: 8852667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery from a variegate porphyria by a liver transplantation.
    Stojeba N; Meyer C; Jeanpierre C; Perrot F; Hirth C; Pottecher T; Deybach JC
    Liver Transpl; 2004 Jul; 10(7):935-8. PubMed ID: 15237381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of variegate porphyria--hard to get?
    von und zu Fraunberg M; Kauppinen R
    Scand J Clin Lab Invest; 2000 Nov; 60(7):605-10. PubMed ID: 11202052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variegate porphyria in South Africa, 1688-1996--new developments in an old disease.
    Hift RJ; Meissner PN; Corrigall AV; Ziman MR; Petersen LA; Meissner DM; Davidson BP; Sutherland J; Dailey HA; Kirsch RE
    S Afr Med J; 1997 Jun; 87(6):722-31. PubMed ID: 9254745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haem arginate improves hepatic oxidative metabolism in variegate porphyria.
    Tokola O; Mustajoki P; Himberg JJ
    Br J Clin Pharmacol; 1988 Dec; 26(6):753-7. PubMed ID: 3242580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variegate porphyria with coexistent decrease in porphobilinogen deaminase activity.
    Weinlich G; Doss MO; Sepp N; Fritsch P
    Acta Derm Venereol; 2001; 81(5):356-9. PubMed ID: 11800145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexistent variegate porphyria and porphyria cutanea tarda.
    Day RS; Eales L; Meissner D
    N Engl J Med; 1982 Jul; 307(1):36-41. PubMed ID: 7078623
    [No Abstract]   [Full Text] [Related]  

  • 38. [A family study of the initial Dutch patients with porphyria].
    te Velde K; Noordhoek KH; Wilson JH; de Roody FW
    Ned Tijdschr Geneeskd; 1989 Dec; 133(51):2547-52. PubMed ID: 2601755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Porphyria cutanea tarda. Diagnosis, management, and differentiation from other hepatic porphyrias.
    Grossman ME; Poh-Fitzpatrick MB
    Dermatol Clin; 1986 Apr; 4(2):297-309. PubMed ID: 3955900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective hepatic anion transport in variegate porphyria.
    Aizawa T; Hiramatsu K; Ohtsuka H; Niwa A; Yukimura Y; Yamada T; Kiyosawa K; Furuta S; Ogata H; Miyamoto H
    Am J Gastroenterol; 1987 Nov; 82(11):1180-5. PubMed ID: 3673999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.